Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 7 years, The Klinique Medical Clinic PCL's highest 3-Year average EPS without NRI Growth Rate was 21.80% per year. The lowest was 10.90% per year. And the median was 13.30% per year.
The Klinique Medical Clinic PCL (BKK:KLINIQ) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
The Klinique Medical Clinic PCL Earnings per Share (Diluted) Related Terms
The Klinique Medical Clinic PCL Earnings per Share (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL Earnings per Share (Diluted) Chart
BKK:KLINIQ vs ROL, SCI, HRB: Earnings per Share (Diluted) Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL PE Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's PE Ratio distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's PE Ratio falls into.
The Klinique Medical Clinic PCL Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of ฿1.92 mean?
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a Earnings per Share (Diluted) of ฿1.92 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on The Klinique Medical Clinic PCL and its competitors. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #38 out of 66 companies in the Personal Services industry, placing it in the top 57.6%.
Is The Klinique Medical Clinic PCL's Earnings per Share (Diluted) too high?
The Klinique Medical Clinic PCL's current Earnings per Share (Diluted) is ฿1.92. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #38 out of 66 companies in the Personal Services industry, which is below the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's Earnings per Share (Diluted) compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #38 out of 66 companies for Earnings per Share (Diluted). This places The Klinique Medical Clinic PCL in the lower half of its industry. The industry median Earnings per Share (Diluted) is 14.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Personal Services company?
The median Earnings per Share (Diluted) among Personal Services companies is 14.35, based on 66 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median Earnings per Share (Diluted) is 14.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current Earnings per Share (Diluted) is ฿1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿41.00, compared to a current price of ฿28.50 — trading 30.5% below its estimated fair value. The current Earnings per Share (Diluted) is ฿1.92. The Klinique Medical Clinic PCL's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current Earnings per Share (Diluted) is ฿1.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿28.50 is trading 30.5% below its estimated GF Value™ of ฿41.00.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
Earnings per Share (Diluted): ฿1.92
GF Value™: ฿41.00 vs. price of ฿28.50 (30.5% below fair value)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score
Get the complete analysis for BKK:KLINIQ
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
